Abstract
dc:descriptionWithin a period of eight years ninety children with thrombosis at various sites were ref- fered to our Haemostasis Unit for laboratory investigation or/and therapeutic intervention. CNS thrombosis represented the majority of cases occurring mostly isolated, without an underlying disease or a trggering event, whereas deep vein thrombosis (DVT), arterial thrombosis (ART) or thrombosis at other sites [right atrium thrombosis (RAT), renal vein thrombosis (RVT)] were mostly associated with one or more risk factors. The prevalence of congenital prethrombotic factors (FV Leiden: 9,3%, FII 20210 A: 3,7%, APCR without the known FV mutation: 3,2%, PS deficiency: 1,3%) was not much higher than in the general population, with the exception of MTHFR (59,5%). More than half of the congenital defects were identified in CNS cases. In contrast, acquired prethrombotic factors (4ΆΤ, PC, PS, Pig, TI, FVIII, LA+ or/and ACA+) were more frequent in DVT, ART or RAT cases, being mostly attributed to an underlying disease. In other words, thrombosis in childhood, seems to be a multifactorial disease and prethrombotic factors have a contributory rather than a causative effect in thrombus development. The mortality rate due to thrombosis was 5,5%. Radiological re-evaluation of fifty three thrombosed children showed complete lysis of the thrombus in 60,4% of cases. Lysis was mostly the result of thrombolytic or/and anticoagulant therapy. On the other hand, the follow up study of 58 thrombosed children for a mean period of 3 years revealed that 41,4% of them presented with clinical sequelae (motor disorders: 19, intracranial hypertension: 3, postphlebitic syndrome: 1, thighs asymmetry: 1). Neurologic sequelae were mainly observed in children with CNS arterial thrombosis (15/19). Recurrent thrombosis occurred in 8,9% of children most of whom had an underlying disease. The high morbidity and mortality of thrombotic disease found in our children justifies the need for multicenter studies to determine the optimal treatment, dosage and duration of therapy.93
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2004
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mantziou, Theodora
- Μάντζιου, Θεοδώρα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24905